Zobrazeno 1 - 6
of 6
pro vyhledávání: '"JA Dominguez Menendez"'
Autor:
E Oñate Muzas, A Revuelta Amallo, E Tamayo Orbegozo, C Vila Gallego, U Blazquez Urtizberea, A Aguirrezabal Arredondo, S Vallinas Hidalgo, JA Dominguez Menendez, M Vara Urruchua
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance The role of the pharmacist in the validation and dispensing of medications is already known. But the increasingly frequent use of high cost drugs makes that role essential for the sustainability of health systems. Aim and ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a2338b55a903767109deee77a1e5279
https://doi.org/10.1136/ejhpharm-2021-eahpconf.144
https://doi.org/10.1136/ejhpharm-2021-eahpconf.144
Autor:
JA Dominguez Menendez, A Aguirrezabal Arredondo, U Blazquez Urtizberea, I Martinez Aguirre, E. Fernández Díaz, M Alonso Diez, A Revuelta Amallo
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance It has been proven that an updated pharmacotherapeutic report means improvements in patient safety and system efficiency. Aim and objectives To describe and analyse medicine reconciliation errors (MRE) and to determine aware
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13787c0033d4ba775feac58a71927428
https://doi.org/10.1136/ejhpharm-2020-eahpconf.305
https://doi.org/10.1136/ejhpharm-2020-eahpconf.305
Autor:
A Aguirrezabal Arredondo, A Llona Armada, JA Dominguez Menendez, I Martinez Aguirre, M Alonso Diez, M. Álvarez Lavín, U Blazquez Urtizberea
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background The neuropathic pain management which is refractory to opioids treatments demands the development of new analgesics or new ways of using our classic medicines. Ketamine is scarcely used as an anaesthetic, but with an increase in indication
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e76950af036886ec4f949ff40fe4f2af
https://doi.org/10.1136/ejhpharm-2019-eahpconf.313
https://doi.org/10.1136/ejhpharm-2019-eahpconf.313
Autor:
I Martinez Aguirre, MJ Yurrebaso Ibarreche, LM Mendarte Barrenechea, M Arrastia Erviti, U Blazquez Urtizberea, N Pardo Santos, I Ibarrola Izquierdo, JA Dominguez Menendez
Publikováno v:
Eur J Hosp Pharm
Background In primary care the computerised physician order entry system (CPOES), treatments on demand must have an associated fixed schedule. This is use in order to calculate monthly collection of the medication. At hospital admission, usually on-d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c95288ca1325506ddafee95244a5c33
https://europepmc.org/articles/PMC7535409/
https://europepmc.org/articles/PMC7535409/
Autor:
LM Mendarte Barrenechea, JA Dominguez Menendez, I. Loizaga Díaz, MJ Yurrebaso Ibarreche, S Vallinas Hidalgo, N Pardo Santos
Publikováno v:
European Journal of Hospital Pharmacy. 22:A169.3-A170
Background The introduction of a computerised physician order entry (CPOE) system in 2010 changed the way of working in our hospital. Previously, the administration of medicines was scheduled by nurses, whereas now it is set in advance by physicians.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2439614c49724e8e41aa49b604eeb827
https://doi.org/10.1136/ejhpharm-2015-000639.407
https://doi.org/10.1136/ejhpharm-2015-000639.407
Autor:
M Gutiérrez Toribio, JA Dominguez Menendez, MP Martínez del Prado, E Fernández Díez, MJ Yurrebaso Ibarreche, A Aguirrezabal Arredondo
Publikováno v:
European Journal of Hospital Pharmacy. 21:A1.3-A2
Background The new guidelines from the American Society of Clinical Oncology (ASCO) recommend full weight-based cytotoxic chemotherapy doses to treat obese patients with cancer, particularly when the goal is cure. Carboplatin is one exception and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d40c7bd81b1742b113fc1df7c9b0c4f
https://doi.org/10.1136/ejhpharm-2013-000436.3
https://doi.org/10.1136/ejhpharm-2013-000436.3